6955 — Shandong Boan Biotechnology Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$3.77bn
- HK$3.37bn
- CNY784.82m
Annual cashflow statement for Shandong Boan Biotechnology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -225 | -332 | -119 | 73.2 | 7.14 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 28.8 | 23.6 | 36.4 | 56.8 | 52.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -99.7 | 33.4 | -18.3 | -321 | -83 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -246 | -202 | -18.6 | -118 | 64.9 |
| Capital Expenditures | -341 | -206 | -295 | -363 | -274 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -91.1 | 106 | 1.19 | 0.011 | 0 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -432 | -101 | -294 | -363 | -274 |
| Financing Cash Flow Items | 1,221 | -224 | 187 | -26.5 | -37.3 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,212 | -0.127 | 283 | 478 | 1,141 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 528 | -298 | -31.6 | -2.98 | 932 |